PPBT

Purple Biotech
PPBT

Overview Fund Trends Analyst Outlook Journalist POV

11 hedge funds and large institutions have $224K invested in Purple Biotech in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

less ownership

Funds ownership: →

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding: →

28% less capital invested

Capital invested by funds: $311K → $224K (-$87.2K)

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

Holders
11
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$412K
Puts
$10K
Net Calls
Net Calls Change

Top Buyers

1
+$23K
2
+$11.7K
3
+$6.97K

Top Sellers

1
-$33K
2
-$28K
3
-$27K
4
Group One Trading
Group One Trading
Illinois
-$5.89K
5
Morgan Stanley
Morgan Stanley
New York
-$1.01K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$49K
2
$33K
3
$33K
4
$26K
5
$25K
6
$23K
7
$21K
8
$12K
9
$1K
10
$1K
11
–
12
–
13
–